Type 2 diabetes and impaired glucose tolerance among cardiac patients

被引:0
|
作者
Enquobahrie, Daniel A.
Dolidze, Nino
Chapidze, Guluara
Vadachkoria, Surab
Soh, Jason
Fitzpatrick, Annette
Williams, Michelle A.
机构
[1] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA
[2] Multidisciplinary Int Res Training Program, Seattle, WA USA
[3] Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA USA
[4] Univ Washington, Sch Publ Hlth & Community Med, Seattle, WA USA
[5] Emergency Cardiol Ctr, Tbilisi, Georgia
[6] Swedish Med Ctr, Ctr Perinatal Studies, Seattle, WA USA
关键词
type; 2; diabetes; cardiovascular disease; dyslipidaemia;
D O I
10.2143/AC.62.5.2023405
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background -Type 2 diabetes (T2D) and impaired glucose tolerance (IGT) are associated with increased cardiovascular diseases (CVD) morbidity and mortality.T2D and IGT prevalence and their relation to other risk factors were investigated among cardiac patients. Methods and results - Patients (n = 250) visiting a secondary prevention clinic at the Emergency Cardiology Centre in Tibilisi, Republic of Georgia were enrolled in the study. Information on medical and surgical histories, CVD risk factors and current medical condition was obtained using interviews, medical record abstraction, physical examination and laboratory studies. Fasting blood glucose and 2-hour post load glucose concentrations were determined. Overall 40.8% (46% among men and 33% among women) of participants had T2D while 13% had IGT (13.4 among men and 12.9 among women). Of the T2D cases, more than half were previously undiagnosed. IGT and T2D were highly associated with dyslipidaemic profiles and elevated inflammatory marker concentrations in this population. Undiagnosed T2D cases shared similar CVD risk factors as previously diagnosed T2D cases including dyslipidaemia, other metabolic syndrome components and inflammation. Conclusion - Both T2D (diagnosed and undiagnosed) and IGT are prevalent; and are associated with other important CVD risk factors among cardiac patients in the Republic of Georgia. Future studies assessing associations of T2D and IGT with CVD morbidity and mortality in this population, as well as studies that assess prevalence of T2D and IGT and their relation with CVD in the general population are needed.
引用
收藏
页码:439 / 444
页数:6
相关论文
共 50 条
  • [1] Characteristics of Korean type 2 diabetes mellitus and impaired glucose tolerance patients
    Son, HY
    [J]. DIABETES MELLITUS: RECENT ADVANCES FOR THE 21ST CENTURY, 2000, 1209 : 15 - 18
  • [2] PHARMACOLOGICAL STRATEGIES FOR PREVENTING TYPE 2 DIABETES IN PATIENTS WITH IMPAIRED GLUCOSE TOLERANCE
    Smith-Marsh, D.
    [J]. DRUGS OF TODAY, 2013, 49 (08) : 499 - 507
  • [3] Antihypertensive drugs as predictors of Type 2 diabetes among subjects with impaired glucose tolerance
    Rajala, U
    Qiao, Q
    Laakso, M
    Keinänen-Kiukaanniemi, S
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2000, 50 (03) : 231 - 239
  • [4] Impaired glucose tolerance and progression to type 2 diabetes in youth
    Krakoff, J
    Hanson, R
    Touger, L
    Bennett, P
    Knowler, W
    [J]. DIABETES, 2003, 52 : A70 - A70
  • [5] Skin capillary density in subjects with impaired glucose tolerance and patients with Type 2 diabetes
    Jaap, AJ
    Shore, AC
    Stockman, AJ
    Tooke, JE
    [J]. DIABETIC MEDICINE, 1996, 13 (02) : 160 - 164
  • [6] Immunosuppressive markers of atherosclerosis in patients with impaired glucose tolerance and type 2 diabetes mellitus
    Chugunova, L. A.
    Galitsina, N. A.
    Sukhareva, O. Y.
    Knyazeva, A. P.
    Shestakova, M. V.
    [J]. DIABETES MELLITUS, 2005, 8 (02): : 54 - 58
  • [7] Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes
    Menge, Bjoern A.
    Schrader, Henning
    Ritter, Peter R.
    Ellrichmann, Mark
    Uhl, Waldemar
    Schmidt, Wolfgang E.
    Meier, Juris J.
    [J]. REGULATORY PEPTIDES, 2010, 160 (1-3) : 75 - 80
  • [8] Pioglitazone preserves pancreatic β-cells in patients with type 2 diabetes and impaired glucose tolerance
    Hamdy, O
    Soodini, G
    Martens, J
    Verheught, C
    Steppel, J
    Caballero, AE
    Bennani, T
    Horton, ES
    [J]. DIABETES, 2005, 54 : A146 - A146
  • [9] Markers of endothelium dysfunction in patients with Type 2 diabetes mellitus and impaired glucose tolerance
    Kowalska, I
    Straczkowski, M
    Stepien, A
    Kinalska, I
    [J]. DIABETOLOGIA, 2002, 45 : A401 - A401
  • [10] Changes of arterial hemodynamics in patients with type 2 diabetes mellitus or impaired glucose tolerance
    Milio, G
    Novo, G
    Ferrara, F
    Raimondi, F
    Novo, S
    [J]. INTERNATIONAL ANGIOLOGY, 2006, 25 (01) : 73 - 77